Cargando…
Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
BACKGROUND: Dermatomyositis is a rare idiopathic inflammatory disease with diverse presentations that can have varying degrees of cutaneous and systemic involvement. This phenotypic heterogeneity makes DM a therapeutic challenge. Some therapeutic drugs, such as hormones and immunosuppressants, have...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107581/ https://www.ncbi.nlm.nih.gov/pubmed/35570320 http://dx.doi.org/10.1186/s40001-022-00693-0 |